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The RNA dependent RNA polymerase of Sendai virus consists of a complex of the large (L) and phosphoprotein (P) subunits where L is
thought to be responsible for all the catalytic activities necessary for viral RNA synthesis. We previously showed that the L protein forms an
oligomer [Smallwood, S., Cevik, B., Moyer, S.A., 2002. Intragenic complementation and oligomerization of the L subunit of the Sendai virus
RNA polymerase. Virology 304, 235–245] and mapped the L oligomerization domain between amino acids 1 and 174 of the protein [Çevik, B.,
Smallwood, S., Moyer, S.A., 2003. The oligomerization domain resides at the very N-terminus of the Sendai virus L RNA polymerase protein.
Virology 313, 525–536]. An internal deletion encompassing amino acids 20 to 178 of the L protein lost polymerase activity but still formed an L–
L oligomer. The first 25 amino acids of paramyxovirus L proteins are highly conserved and site-directed mutagenesis within this region eliminated
the biological activity of the L protein but did not have any effect on P–L or L–L interactions. Moreover deletion of amino acids 2–18 in L
abolished biological activity, but again the L–L binding was normal demonstrating that the oligomerization domain of L protein resides in two N-
terminal regions of the protein. Therefore, sequences between both aa 2–19 and aa 20–178 can independently mediate Sendai L oligomerization,
however, both are required for the activity of the protein.
© 2007 Elsevier Inc. All rights reserved.Keywords: Transcription; Replication; Sendai virus polymeraseIntroduction
Sendai virus (SeV) is a member of the genus Respirovirus of
the Paramyxovirinae subfamily of the nonsegmented negative
strand RNA viruses. It has a single-stranded genome of 15,384
nucleotides (nt) organized into six open reading frames
encoding the NP, P/C/V, M, F, HN and L proteins. The genome
is encapsidated by the nucleocapsid protein (NP) in a helical
nucleocapsid which serves as the template for all viral RNA
synthesis (Lamb and Kolakofsky, 2001). The RNA dependent
RNA polymerase (RdRp) of SeV consists of the phosphoprotein
(P, 528 amino acids [aa]) and the large protein (L, 2228 aa)
subunits. P protein is a tetramer forming a coiled coil structure
(Tarbouriech et al., 2000a, 2000b). Although the structure of the⁎ Corresponding author. Fax: +1 352 846 2042.
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doi:10.1016/j.virol.2007.01.032L protein has not been determined, we recently demonstrated
that SeV L protein forms an oligomer (Smallwood et al., 2002),
thus the minimal composition of the polymerase complex is
L2–P4. Formation of functional SeV RdRp requires the
coexpression of the P and L proteins. P binding stabilizes the
L protein probably by facilitating its correct folding (Horikami
et al., 1992; Horikami et al., 1997), but it is not required for
oligomerization of L (Çevik et al., 2003). The P–L interaction
has been extensively studied and the binding sites in both
proteins have been identified. The L binding site was mapped to
aa 412–479 on SeV P (Curran et al., 1994; Smallwood et al.,
1994). The P binding site on the SeV L protein was first mapped
to the first 400 aa by deletion analysis of the L gene (Chandrika
et al., 1995; Horikami et al., 1994). Specific residues of SeV L
protein involved in P binding were identified by site directed
mutagenesis within aa 21–350 of L (Holmes and Moyer, 2002).
The P proteins of SV5 and rinderpest viruses similarly bind to
the N-terminus of their respective L proteins (Parks, 1994;
Chattopadhyay and Shaila, 2004).
Fig. 1. L–L and P–L complex formation with an internal deletion of L. VVT7
infected cells were either not transfected (Mock) or transfected with the
indicated HA-L BaK (A) or P (B) plasmids in the absence or presence of the
FLAG-L WT or FLAG-L BsmI plasmids. The cells were radiolabeled with
Express-35S, cytoplasmic cell extracts prepared and either separated by SDS-
PAGE directly (Total) or after IP with α-FLAG antibody (α-FLAG). The
positions of the proteins are indicated.
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the catalytic functions required for RNA synthesis. Sequence
comparisons of the L proteins from a number of non-segmented
negative strand RNA viruses revealed the presence of six
conserved domains which were presumed to be involved in
specific activities of L proteins (Poch et al., 1990; Sidhu et al.,
1993). Characterization of SeV L mutants in each of the six
domains by site directed mutagenesis revealed that mutation in
different domains resulted in similar or the same defective
phenotype suggesting that multiple domains contribute to the
different steps in viral RNA synthesis (Chandrika et al., 1995;
Cortese et al., 2000; Feller et al., 2000; Horikami and Moyer,
1995; Smallwood et al., 1999, 2002). Coexpression of two
inactive L mutants with mutations in different domains showed
intragenic complementation restoring viral RNA synthesis
suggesting that the L protein may form an oligomer. We
demonstrated oligomerization of L protein directly by the
coimmunoprecipitation of differentially epitope tagged full
length and truncated L proteins and showed by progressive
deletion from the C and N terminus that the L–L interaction was
mediated by aa 1–174 (Smallwood et al., 2002; Çevik et al.,
2003). The oligomerization of L protein was also shown for
human parainfluenza virus 3 (hPIV3) (Smallwood and Moyer,
2004) and measles virus (Çevik et al., 2004) and the binding
domain was mapped to the N-terminal half of the respective L
proteins. These data suggest that oligomerization of L protein is
common feature of paramyxoviruses. In recent work, moreover,
the L protein of lymphocytic choriomeningitis virus, an
arenavirus, was also shown to be an oligomer (Sanchez and
de la Torre, 2005). In this study we show that a bipartite region
within the very N-terminus is required for the oligomerization
of the L protein of SeV.
Results and discussion
FLAG-L BsmI internal deletion mutant of L separates L–L and
L–P binding sites
We previously demonstrated that deletion of aa 1–174 of the
SeV L protein abolished both L–L and L–P binding, however,
site directed mutagenesis encompassing this region showed that
different amino acids in L were required for each of these
interactions (Çevik et al., 2003). In addition just aa 1–174 could
induce oligomerization of a heterologous protein that did not
normally form a complex (Çevik et al., 2003). To further study
L complex formation, aa 20–178 of L in the FLAG-L protein
were deleted by BsmI digestion of the gene as described in
Materials and methods. To test for oligomerization of this L
mutant, VVT7 infected cells were transfected with the HA-L
BaK plasmid which contains the N-terminal 1146 aa of L alone
or together with the FLAG-L WT or FLAG-L BsmI plasmids
and labeled with Express-35S. Gel analysis of total cytoplasmic
cell extracts showed that all the L proteins were synthesized
(Fig. 1A, Total). Immunoprecipitation (IP) with α-FLAG
antibody gave only a small background amount of HA-L BaK
protein when it was expressed alone (Fig. 1A, α-FLAG, lane 2),
showing the specificity of the antibody. As a positive controlHA-L BaK was coimmunoprecipitated by the α-FLAG anti-
body when coexpressed with FLAG-L WT, and also when
expressed with FLAG-L BsmI (Fig. 1A, α-FLAG, lanes 3 and
4). The band in lane 4 just below HA-L BaK appears to be a
mock band (see totals) that in just this sample was also
immunoprecipitated. Only background amounts of this band
were immunoprecipitated in other experiments, like in lanes 1–
3 of Fig. 1B. These data suggest that the L oligomerization site
resides in the N-terminal 19 aa and not in the deleted region of
the L protein.
The internal deletion mutant was also tested for the ability to
bind to SeV P. VVT7 infected cells were transfected with the P
plasmid alone or together with FLAG-L WT or FLAG-L BsmI
plasmids and pulse labeled with Express-35S. Gel analysis of
Fig. 2. In vitro transcription with site-directed SeV L mutants. (A) Comparison
of sequences at the N-terminus of paramyxovirus L proteins. hPIV2 or 3, human
parainfluenza virus 2 or 3; RPV, rinderpest virus; PDV, phocine distemper virus;
SV5, simian virus 5; NDV, Newcastle disease virus. The positions indicated
above: 2–4; 5–7; 8–10; 11–13; 14; 15; and 16–18 were changed to alanine in
the mutant. (B) VVT7 infected cells were either Mock transfected or transfected
with the indicated P and WT or mutant L plasmids. After 18 h cytoplasmic cell
extracts were incubated with SeV polymerase-free RNA-NP template and
[α-32P]CTP. Total RNA was isolated and analyzed on an agarose urea gel as
described under Materials and methods. The position of the NP and P mRNAs is
indicated. The data from two experiments were quantitated and expressed as the
% transcription (Tnx) after subtracting the activity of the Mock compared to wt
L as 100%. The values of two experiments varied by less than 10%. (C)
Immunoblot analysis of samples of the extracts with α-FLAG and α-P
antibodies. The positions of the proteins are indicated.
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(Fig. 1B, total) and IP with α-FLAG antibody did not show any
P protein when it was expressed alone (Fig. 1B, α-FLAG, lane
2). However, P protein was coimmunoprecipitated when it was
coexpressed with FLAG-L WT, but not with FLAG-L BsmI
(Fig. 1B, α-FLAG, lanes 3 and 4) showing that the deleted
region was required for P binding. These data are consistent
with our previous finding that although both the P and L binding
sites are located in N-terminus of L, different amino acids are
involved in these interactions (Çevik et al., 2003).
Site directed mutagenesis in the N-terminus abolishes the
activity of L protein
We previously demonstrated that the L proteins from SeV,
hPIV3 and measles virus all form an oligomer (Smallwood et
al., 2002; Çevik et al., 2003, 2004; Smallwood and Moyer,
2004), suggesting there may be conserved sequences in the L
proteins involved in oligomerization. Analysis of the internal
deletion at the N-terminus (Fig. 1) suggested that the first 19 aa
of SeV L protein may be required for oligomerization, and
sequence analysis (Poch et al., 1990; Sidhu et al., 1993) showed
that aa 13–25 were highly conserved in the L protein of
paramyxoviruses (Fig. 2A). To determine the importance of this
region for the formation and activity of the polymerase
complex, seven alanine scanning site-directed L mutations
from aa 2–18 were constructed as described in Materials and
methods. In a previous study mutagenesis of aa 20–25
inactivated the SeV polymerase by abolishing P but not L
binding (Holmes and Moyer, 2002).
The mutant L proteins were tested for their biological
activity. For transcription VVT7 infected cells were mock
transfected or transfected with the P and WTor mutant FLAG-L
plasmids. Cytoplasmic extracts were prepared and incubated
with polymerase-free WT RNA-NP template and [α-32P]CTP,
and the total transcription products were analyzed by gel
electrophoresis as described under Materials and methods. No
transcription was observed in the absence of viral proteins
indicating that the template was free of endogenous polymerase,
but significant RNA synthesis occurred with FLAG-L WT
protein as expected (Fig. 2B, lanes 1 and 2). FLAG-L 5–7 and
11–13 gave about one third the activity of WT L (Fig. 2B, lanes
4 and 6), however, the activity of all the other mutants including
the single mutations at aa 14 and 15 was almost or completely
abolished (lanes 3, 5, 7–9). Immunoblot analysis of a portion of
the cell extracts showed that P protein and the FLAG-L mutants
were all expressed, and although the amounts of two of the
inactive L mutants (5–7 and 16–18) were somewhat reduced
this did not account for their complete loss of activity. Thus
conserved residues (aa 14, 16, 17) as well as non-conserved
amino acids (aa 2–4, 8–10, 18) are required for polymerase
function.
The L mutants were also assayed for biological activity in
supporting DI-H genome replication in vitro. Cytoplasmic
extracts of cells expressing each of the WTand mutant FLAG-L
proteins together with the P and NP proteins were prepared and
incubated with polymerase-free DI-H RNA-NP template in thepresence of [α-32P]CTP. The nuclease resistant replication
products were isolated and analyzed as described under
Materials and methods. In vitro DI-H RNA replication occurred
with the WT L protein, but no replication occurred in the
absence of viral proteins (Fig. 3A top, lanes 1 and 2) showing
Fig. 3. In vitro and in vivo DI-H RNA replication with the site directed L mutants. (A) VVT7-infected A549 cells were transfected with no plasmids (Mock) or
cotransfected with the NP and P plasmids together with the indicated WT or mutant L plasmids. Cytoplasmic cell extracts were incubated with polymerase-free DI-H
RNA-NP template in the presence of [α-32P]CTP. RNA was extracted from nuclease resistant nucleocapsid products and analyzed by gel electrophoresis (top) as
described under Materials and methods. (B) VVT7-infected A549 cells were transfected with DI-H plasmid alone (Mock) or cotransfected with the DI-H, NP and P
plasmids together with the indicated WT or mutant L plasmids. Cytoplasmic cell extracts were nuclease treated, the RNA extracted and detected by Northern blot
analysis with a (−) strand specific DI-H riboprobe (top) as described under Materials and methods. The position of DI-H RNA is indicated. The amount of DI-H
product (Rep) was quantitated on a phosphorimager and calculated relative to WT L as 100%, where in 2–3 experiments the values varied by <10%. (Bottom)
Immunoblot analysis on samples of the extracts with α-FLAG and α-SeV antibodies, where the positions of the L, P and NP proteins are indicated.
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dependent on added viral proteins. The mutant proteins FLAG-
L 2–4, 5–7 and 11–13 gave significant or close to WT
replication activity (75%, 93% and 95% of FLAG-L WT
protein, respectively) (Fig. 3A top, lanes 3, 4 and 6). A
significant difference from the transcription results for these
mutants was that FLAG-L 2–4 was active in DI-H replication
but reduced by 92% in mRNA synthesis (Fig. 2). The
replication activities of mutant proteins FLAG-L 8–10, 14, 15
and 16–18 were abolished (Fig. 3A, top, lanes 5, 7, 8 and 9)
similar to the results with transcription (Fig. 2). Immunoblot
analysis of a portion of the cell extracts showed that the L, NP
and P proteins were all expressed (Fig. 3A, bottom).
The activities of the N-terminal site directed FLAG-L
mutants were also tested for their activity in replication in
vivo. This assay differs from its in vitro counterpart in that
following VVT7 infection, cells were transfected with a plasmid
containing a cDNA copy of the DI-H genome along with
plasmids encoding P, NP and the indicated FLAG-Lmutants. T7
transcription from the DI-H plasmid yields (+) sense DI-H
genome RNA, which is then nonspecifically encapsidated by the
NP protein encoded by pGEM-NP. The encapsidated (+) sense
DI-H is then replicated in vivo by the viral polymerase with
multiple rounds of amplification required to detect product.
Extracts of the cells were prepared and digested with micro-
coccal nuclease to eliminate any non-encapsidated RNA. The
nuclease-resistant (−) sense replication products were then
isolated, separated by gel electrophoresis, and detected byNorthern blot analysis with a (+) sense DI-H genome riboprobe.
In the absence of viral proteins no DI-H RNA was replicated,
while full-length DI-H RNAwas synthesized in the presence of
the WT viral proteins (Fig. 3B top, lanes 1 and 2). The mutants
FLAG-L 2–4, 5–7 and 11–13 which all showedWT levels of in
vitro replication activity (Fig. 3A) gave somewhat reduced
levels of in vivo replication ranging from 28% to 43% of WT L
(Fig. 3B top, lanes 3, 4 and 6). This is due to the difference in the
assays where in vivo replication is more sensitive to partial
defects since multiple rounds of replication give an additive
effect not seen in the single round of replication assayed in vitro.
All the other N-terminal mutants, however, were inactive in
replication in vivo (Fig. 3B top) as they were in vitro.
Immunoblot analysis showed that all the proteins were
expressed and the defects in the replication activity were not
due to limited protein (Fig. 3B, bottom). Thus one or more of the
amino acids in the blocks of 8–10 and 14–18 in the N-terminal
region of L were essential for virus replication in vivo and in
vitro.
The SeV L mutant changing aa 2–4 to alanine gave the
interesting result that transcription was significantly impaired
(only 8% of WT) while replication was still significant (75%
of WT). In our previous studies of a significant number of
SeV L mutants (Chandrika et al., 1995; Cortese et al., 2000;
Feller et al., 2000; Horikami and Moyer, 1995; Smallwood et
al., 1999, 2002) we have never identified any other mutant
with this phenotype. There were a number of L mutants that
were inactive in both transcription and replication as well as
Fig. 4. P–L complex formation is not inhibited by the site-directed mutant L
proteins. (A and B) VVT7 infected cells were either not transfected (Mock) or
transfected with the indicated FLAG-LWT or mutant plasmids with P plasmid
and incubated overnight. Cytoplasmic extracts were prepared and (A) total
samples analyzed by immunoblot with α-P and α-FLAG antibodies or (B)
samples were immunoprecipitated with α-P, separated by SDS-PAGE and
immunoblotted with α-FLAG. (C) The cells were transfected with gstP plasmid
and the WT or mutant L plasmids and radiolabeled with Express-35S for 1 h at
16 h p.t. Cytoplasmic cell extracts were prepared and separated by SDS-PAGE
after binding to glutathione-Sepharose beads. The positions of the proteins are
indicated.
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replication. Apparently by unknown mechanisms different
mutations can differentially and selectively affect either trans-
cription or replication. In a study of the hPIV3 L protein a
deletion of aa 2–5 gave a mutant that could still both transcribe
and replicate, although at 30% of the level of WT L (Malur
et al., 2002), so different viruses may respond differently to
mutation.
N-terminal site directed L mutants form P–L and L–L
complexes
Some site directed mutagenesis in the very N-terminus of the
SeV L protein eliminated or significantly reduced polymerase
activity suggesting that these mutants might be unable to form
functional polymerase complexes which requires both P–L and
L–L interactions. The mutants were analyzed for both
complexes by pull down experiments. VVT7 infected cells
were transfected with P plasmid alone or together with the WT
or mutant FLAG-L plasmids and incubated overnight. Immu-
noblot analysis of the total samples showed that all the proteins
were synthesized except FLAG-L 16–18 which was quite low
in this experiment (Fig. 4A). When the P protein was
coexpressed with WT and mutant L proteins, IP with α-P
antibody followed by immunoblotting with α-FLAG antibody
showed that WT L and all the FLAG-L mutants coimmuno-
precipitated with P in proportion to the amount of L protein
synthesized (Fig. 4B), indicating that none of these mutations
affected L binding to P protein. To confirm these results gstP
was coexpressed with the L mutants and labeled with
Express-35S. The GST bead binding showed that gstP alone
bound to the beads, while the FLAG-LWT protein alone did not
(Fig. 4C, lanes 2 and 3) as expected. When coexpressed with
gstP, FLAG-L WT as well as all the L mutants cobound to the
beads (Fig. 4C, lanes 4–11), showing again that all the L
mutants formed a complex with P protein.
To test for oligomerization of the L mutants VVT7 infected
cells were transfected with the WTor mutant FLAG-L plasmids
and the truncated HA-L Bak plasmid and pulse labeled with
Express-35S. Gel analysis of the total samples showed that all
the proteins were synthesized (Fig. 5A). IP with α-FLAG
antibody brought down WT FLAG-L, but not HA-L BaK,
when they were expressed alone (Fig. 5B, lanes 2 and 3),
however, when HA-L BaK was coexpressed with FLAG-LWT
it was coimmunoprecipitated by α-FLAG antibody (Fig. 5B,
lane 4). Similarly HA-L BaK was coimmunoprecipitated with
α-FLAG antibody when it was coexpressed with each of the
site directed L mutants (Fig. 5B, lanes 5–11). These data show
that all the individual mutants in the very N-terminal region of
L protein are still able to form both P–L and L–L interactions,
yet for the L mutants that synthesize no RNA one or both of
these interactions must somehow be defective. One possibility
is that the mutants bind L or P incorrectly due to the mutations,
and thus do not fold correctly giving inactive complexes.
Alternatively the lack of activity could be due to an unknown
defect(s) in other steps in RNA synthesis that go beyond these
protein–protein interactions.A small N-terminal deletion mutant also loses functional
activity but retains protein–protein interactions
Since limited amino acid changes in the very N-terminus of
L did not overtly affect the protein–protein interactions it was
Fig. 5. L–L complex formation occurs with the site-directed L mutants. VVT7 infected cells were either not transfected (Mock) or transfected with HA-L BaK and the
indicated WT or mutant L plasmids. The cells were radiolabeled with Express-35S for 1 h at 16 h p.t. Cytoplasmic cell extracts were prepared and either separated by
SDS-PAGE directly (A, Total) or after IP (B) with α-FLAG antibody. The positions of the proteins are indicated.
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actually inhibit binding of P and/or L. Accordingly we deleted
aa 2–18 (Δ2–18) in FLAG-L and tested for function and
protein binding. Extracts of cells expressing P with FLAG-L
Δ2–18 or FLAG-L BsmI which deletes aa 20–178 gave no
transcription compared to WT L (Fig. 6A). Similarly cell
extracts expressing P and NP with these L deletions also were
completely inactive in DI-H replication (Fig. 6B). This was
expected since some of the individual changes in LΔ2–18 were
inactive (Figs. 2 and 3) and the BsmI deletion could not bind PFig. 6. Transcription and replication with SeV L deletion mutants. (A) VVT7
infected cells were either Mock transfected or transfected with the P and the
indicated WT or deletion L plasmids. After 18 h cytoplasmic cell extracts were
incubated with polymerase-free wt RNA-NP template and [α-32P]CTP. Total
RNA was isolated and analyzed on an agarose urea gel as described under
Materials and methods. The position of the NP and P mRNAs is indicated. (B)
VVT7 infected cells were transfected with no plasmids (Mock) or cotransfected
with the NP and P plasmids together with the indicated WT or mutant L
plasmids. Cytoplasmic cell extracts were incubated with polymerase-free DI-H
RNA-NP template in the presence of [α-32P]CTP. RNA was purified from
nuclease resistant nucleocapsid products and analyzed by gel electrophoresis as
described under Materials and methods. The position of DI-H RNA is indicated.(Fig. 1). To test for P–L and L–L protein–protein interactions
the Δ2–18 deletion was expressed with either gstP or HA-L
BaK, respectively as described above. In each case the proteins
were all expressed (Figs. 7A and B, Total). P protein bound to
the deletion L Δ2–18 like WT L since each L protein cobound
with gstP to glutathione beads (Fig. 7A, Beads). Interestingly L
Δ2–18 also still retained the ability to oligomerize since
compared to the controls, the α-HA antibody coimmunopreci-
pitated L Δ2–18 with HA-L BaK (Fig. 7B). Apparently
sequences between both aa 2–19 and aa 20–178 can
independently mediate L oligomerization, however, both are
required for the activity of the protein as indicated in Fig. 8.
Similar site directed mutagenesis was performed on the
conserved N-terminal region of the L protein of hPIV3 byMalur
et al. (2002) to study the effect of the mutant polymerase
complex on viral RNA synthesis and P protein binding.
Mutation of amino acids 14 and 15 which are identical in
both SeV and PIV3 gave similar results in the two L proteins
where at least some P protein binding is retained, but the
polymerase complex is inactive. However, in the case of PIV a
deletion of aa 2–15 did abolished P binding, while for SeV L a
deletion of aa 2–18 retained P binding, and as expected both
proteins were inactive. Thus conserved residues in the N-
terminus of L are essential for polymerase function although the
details appear slightly different.
While the L proteins of a number of negative strand RNA
viruses appear to form oligomers, the function and degree of L
oligomerization in the polymerase P–L complex are unknown.
One possibility is that oligomerization is required for the
binding of Sendai L to the 4 subunits of the P protein. Moreover,
L protein has multiple functions in viral RNA synthesis that
may require oligomerization to create the enzymatic activities.
The finding that L shows intragenic complementation (Small-
wood et al., 2002) clearly demonstrates that each subunit of L
in the polymerase complex is essential and can function
Fig. 7. P–L and L–L complex formation with the Δ2–18 L mutant. (A) VVT7 infected cells were either not transfected (Mock) or transfected with the indicated
FLAG-LWT or Δ2–18 plasmids with gstP plasmid and radiolabeled with Express-35S. Cytoplasmic cell extracts were prepared and either separated by SDS-PAGE
directly (Total) or after binding to glutathione-Sepharose beads. The positions of the proteins are indicated. (B) VVT7 infected cells were either Mock transfected or
transfected with the FLAG-LWTor FLAG-L Δ2–18 plasmids in the absence or presence of HA-L BaK plasmid and radiolabeled with Express-35S. Cytoplasmic cell
extracts were prepared and either separated by SDS-PAGE directly (Total) or after IP with α-HA antibody. The positions of the proteins are indicated.
Fig. 8. Schematic diagram of L protein and the regions of protein–protein complex formation. The wild type FLAG-tagged L protein is indicated at the top with the
conserved domains I–VI indicated by boxes above. The three truncated and deletion proteins are indicated below where the dotted box on FLAG-LΔBsu shows the
deletion with their sizes indicated on the right. At the bottom are indicated by boxes the regions of L required for L binding and for P binding.
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complex of a non-segmented negative strand RNAvirus will be
needed to understand its structure and function and the
phenotypes of the various L mutants.
Materials and methods
Cells, viruses, plasmids and antibodies
Human lung carcinoma cells (A549 cells, ATCC) were used
for all experiments. Recombinant vaccinia virus expressing the
phage T7 RNA polymerase (VVT7) (Fuerst et al., 1986) was
grown on A549 cells. Sendai virus (Harris) and the Sendai virus
defective interfering particle (DI-H) were propagated on
embryonated chicken eggs and wildtype (WT) polymerase-
free Sendai and DI-H templates were prepared as described
previously (Carlsen et al., 1985). Plasmids encoding the SeV
virus genes, pGEM-L, pGEM-NP, pGEM-Pstop (expressing
only the P protein and not the C proteins, designated here as
pGEM-P) were described previously (Curran et al., 1991). The
HA and FLAG-tagged SeV L plasmids, pGEM-HA-L, pGEM-
HA-L BaK and pGEM-FLAG-L, were described previously
(Çevik et al., 2003, see Fig. 8) and the pTM-gstP plasmid was
described in Chandrika et al. (1995). The genes were all cloned
downstream of the T7 promoter. Antibodies utilized for
immunoblot and immunoprecipitation assays were anti-Sendai
virus (α-SV) and anti-P peptide rabbit antibodies (Çevik et al.,
2003), anti-FLAGM-2 monoclonal antibody (α-FLAG, Sigma)
and anti-HA probe F-7 monoclonal antibody (α-HA, Santa
Cruz Biotechnology, Inc).
Construction of L mutants
The FLAG-L BsmI deletion was constructed by digestion of
FLAG-L at the two BsmI sites and religation to make an in
frame deletion of aa 20–178 of L (see Fig. 8). The site directed
mutants were constructed by changing the amino acids in
FLAG-L at positions 2–4, 5–7, 8–10, 11–13, 14, 15 and 16–18
to alanine by oligonucleotide directed mutagenesis with the
Quick Change Mutagenesis Kit (Stratagene). The changes were
verified by sequencing. The FLAG-L Δ2–18 deletion was
constructed by overlap PCR deleting aa 2–18.
Protein analysis
For the analysis of protein–protein interactions A549 cells in
35 mm dishes were infected with VVT7 at a m.o.i. of 2.5 pfu/cell
for 1 h at 37 °C and then transfected with pGEM-P (2 μg) or
pTM-gstP (0.1 μg) and wt or mutant pGEM-FLAG-L or pGEM-
HA-L BaK (2 μg) with Lipofectamine (Life Technologies) in
Opti-MEM according to the manufacturer's protocol as indicated
in the figure legends. Fifteen hours post-transfection the cells
were labeled with Express-[35S] (100 μCi/ml, Dupont NEN) in
medium with 0.1× cysteine and methionine for 1 h. Cytoplasmic
extracts were prepared in 200 μl NP-40 lysis buffer [0.15 M
NaCl, 50 mMTris–HCl (pH 8.0), 1%Nonidet P-40 (NP-40), and
1 μg/ml aprotinin]. The cell lysate was clarified by pelleting for30 min at 15,000 rpm. For immunoprecipitation the extracts were
incubated with α-HA (1 μg) or α-FLAG (2 μg) antibodies and
selected with Protein A Sepharose CL 4B (Pharmacia) according
to manufacturer's instructions. Samples containing gstP were
selected with glutathione-Sepharose beads. Total and selected
samples were analyzed by 7.5% SDS-PAGE and autoradiogra-
phy. When unlabeled extracts were analyzed, samples were
immunoprecipitated with one antibody and then immunoblotted
with the second antibody as described below.
The samples of extracts used for RNA synthesis were
separated by 7.5% SDS-PAGE and electroblotted onto PVDF
membrane (Osmonics). The blots were incubated with the
primary antibody, α-HA (0.4 μg/ml) or α-FLAG (4 μg/ml)
antibodies or α-SeVantibody, as indicated in the figure legends
and developed with HRP-conjugated rabbit anti-mouse sec-
ondary antibody or HRP-conjugated goat anti-rabbit as
appropriate using the Enhanced Chemiluminescence Plus
(ECL+) protein detection system (Amersham Life Science).
RNA synthesis
For in vitro mRNA synthesis 60 mm dishes of A549 cells
were infected with VVT7 and transfected with the P (1.5 μg)
and the WT or mutant L (0.5 μg) plasmids with Lipofectamine.
At 18 h post transfection (p.t.) cytoplasmic cell extracts (100 μl)
were prepared by lysolecithin permeabilization, micrococcal
nuclease treated and assayed for transcription with 1 μg
polymerase-free wt SeV nucleocapsid template (RNA-NP),
and 20 μCi of [α-32P]CTP as described previously (Chandrika
et al., 1995; Horikami et al., 1992). RNAwas isolated using the
Qiagen RNeasy™ Total RNA kit according to the manufac-
turer's protocol, and analyzed by 1.5% agarose/6 M urea-citrate
gel electrophoresis.
For in vitro replication 60 mm dishes of A549 cells were
infected with VVT7 and transfected with the WT or mutant L
(0.5 μg), P (5 μg) and the NP (2 μg) plasmids and cell extracts
assayed for replication with 50 μCi [α-32P]CTP, and 2 μg
polymerase free DI-H RNA-NP as described previously
(Chandrika et al., 1995). The samples were then digested with
micrococcal nuclease (MN) (20 μg/ml) with 1 mM CaCl2 for
30 min at 30 °C followed by 2.2 mM EGTA to inactivate the
MN. The nuclease-resistant nucleocapsid RNA was isolated
using the Qiagen RNeasy Total RNA kit, and analyzed by
electrophoresis on a 1.5% agarose/6 M urea-citrate gel.
For in vivo replication, infected cells were transfected as for
in vitro replication with the L, NP and P plasmids with the
addition of plasmid pSPDI-H (2.5 μg). Extracts were prepared,
treated with micrococcal nuclease as above, and the nuclease-
resistant nucleocapsid RNA isolated using the Qiagen
RNeasy™ Total RNA kit. The RNA was separated on a 1.5%
agarose/6 M urea gel and transferred to Hybond-N nylon
membrane and the DI-H replication products (− sense) were
detected by Northern Blot analysis with 32P-labeled T7 DI-H
transcript (+ sense) generated from XbaI-linearized pSPDI-H
plasmid as described previously (Chandrika et al., 1995). The
RNA products were visualized by autoradiography and
quantitated on the phosphorimager (Molecular Dynamics).
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